Literature DB >> 11851724

Effects of deoxycholate on human colon cancer cells: apoptosis or proliferation.

V Milovic1, I C Teller, D Faust, W F Caspary, J Stein.   

Abstract

BACKGROUND: Deoxycholic acid has long been attributed as a tumour promoter in the colon. It exerts its growth-related actions in a phorbol ester-like manner, by stimulating protein kinase C. The aim of this study was to investigate the effect of deoxycholic acid on proliferation and apoptosis in the colon, by exposing colon cancer cells to it in increasing concentrations.
METHODS: Human colon cancer cells (Caco-2 and HT-29) were treated with deoxycholate or its two structural isomers, 3-beta-12-alpha-dihydroxy-5-beta-cholan-24-oic acid and 3-alpha-12-beta-dihydroxy-5-beta-cholan-24-oic acid. Proliferation was evaluated by cell counting, and apoptosis by estimating percentage cell survival and assessment of nuclear morphology.
RESULTS: Within the concentration range of up to 20 microM, deoxycholate stimulated growth of both human colon cancer cell lines. Its growth-promoting effect was abolished after inhibition of protein kinase C. At concentrations above 100 microM, deoxycholate induced apoptosis in both cell lines. Epimers of deoxycholate were significantly less potent in stimulating growth.
CONCLUSION: Low-dose deoxycholate stimulates colon cancer cell proliferation while > 100 micromol L(-1) of this secondary bile acid induces apoptosis in colon cancer cells. Deoxycholate might promote the likelihood of malignant transformation by increasing epithelial cell turnover in the colon.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11851724     DOI: 10.1046/j.0014-2972.2001.00938.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  27 in total

1.  Bile salts inhibit growth and induce apoptosis of culture human normal esophageal mucosal epithelial cells.

Authors:  Ru Zhang; Jun Gong; Hui Wang; Li Wang
Journal:  World J Gastroenterol       Date:  2005-11-07       Impact factor: 5.742

2.  MiR-22-silenced cyclin A expression in colon and liver cancer cells is regulated by bile acid receptor.

Authors:  Fan Yang; Ying Hu; Hui-Xin Liu; Yu-Jui Yvonne Wan
Journal:  J Biol Chem       Date:  2015-01-17       Impact factor: 5.157

3.  Atherogenic diet causes lethal ileo-ceco-colitis in cyclooxygenase-2 deficient mice.

Authors:  James A Lin; Junji Watanabe; Nora Rozengurt; Ajay Narasimha; Martin G Martin; Jenny Wang; Jonathan Braun; Robert Langenbach; Srinivasa T Reddy
Journal:  Prostaglandins Other Lipid Mediat       Date:  2007-04-25       Impact factor: 3.072

Review 4.  Does abnormal bile acid metabolism contribute to NEC?

Authors:  Melissa D Halpern; Bohuslav Dvorak
Journal:  Semin Perinatol       Date:  2008-04       Impact factor: 3.300

5.  Characterization of enantiomeric bile acid-induced apoptosis in colon cancer cell lines.

Authors:  Bryson W Katona; Shrikant Anant; Douglas F Covey; William F Stenson
Journal:  J Biol Chem       Date:  2008-12-03       Impact factor: 5.157

6.  Oncogenic K-ras promotes early carcinogenesis in the mouse proximal colon.

Authors:  Shelly R Calcagno; Shuhua Li; Migdalisel Colon; Pamela A Kreinest; E Aubrey Thompson; Alan P Fields; Nicole R Murray
Journal:  Int J Cancer       Date:  2008-06-01       Impact factor: 7.396

7.  Deoxycholic acid activates beta-catenin signaling pathway and increases colon cell cancer growth and invasiveness.

Authors:  Rama Pai; Andrzej S Tarnawski; Teresa Tran
Journal:  Mol Biol Cell       Date:  2004-03-05       Impact factor: 4.138

8.  Bile acids as endogenous etiologic agents in gastrointestinal cancer.

Authors:  Harris Bernstein; Carol Bernstein; Claire M Payne; Katerina Dvorak
Journal:  World J Gastroenterol       Date:  2009-07-21       Impact factor: 5.742

9.  Deoxycholyltaurine rescues human colon cancer cells from apoptosis by activating EGFR-dependent PI3K/Akt signaling.

Authors:  Jean-Pierre Raufman; Jasleen Shant; Chang Yue Guo; Sanjit Roy; Kunrong Cheng
Journal:  J Cell Physiol       Date:  2008-05       Impact factor: 6.384

10.  The bile acid nuclear receptor FXR and the bile acid binding protein IBABP are differently expressed in colon cancer.

Authors:  Andrea De Gottardi; Fethi Touri; Christoph A Maurer; Anne Perez; Olivier Maurhofer; Giovanni Ventre; Craig L Bentzen; Eric J Niesor; Jean-François Dufour
Journal:  Dig Dis Sci       Date:  2004-06       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.